We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Tocilizumab (rch)
Australian Public Assessment Report
Device/Product Name
Actemra
Active ingredients
Tocilizumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM-2021-04601-1-2
Submission Type
Extension of indications
Decision
Approved for provisional registration